High In-Plane Resolution T2-Weighted Magnetic Resonance Imaging of Acute Myocardial Ischemia in Pigs Using the Intravascular Contrast Agent NC100150 Injection

Rationale and Objectives:The intravascular contrast agent NC100150 injection was tested for its ability to demarcate nonperfused myocardium in a porcine model of coronary occlusion. Materials and Methods:A T2-weighted fast spin echo sequence was acquired ex vivo and in vivo during first pass and steady-state circulation of the contrast agent in 2 dosages (2 and 5 mg Fe/kg bw) or saline. Results:Ex vivo, in the high-dose group, the volume of nonperfused myocardium determined from T2-weighted images was 99% of that determined from photographs where perfused myocardium stained with fluorescein. A significantly higher contrast to noise ratio between perfused and nonperfused myocardium was found (both ex and in vivo in steady state) compared with the control group. During first pass, a significant reduction in signal intensity (74 ± 18%) was found in perfused myocardium after contrast injection. Conclusion:NC100150 injection, combined with T2-weighted turbo spin echo imaging, allowed detailed visualization of non-perfused myocardium in the steady state, which corresponded to the area at risk as determined by fluorescein.

[1]  R. Brasch,et al.  Rationale and applications for macromolecular Gd‐based contrast agents , 1991, Magnetic resonance in medicine.

[2]  A. Bjørnerud,et al.  NC100150 injection, a preparation of optimized iron oxide nanoparticles for positive‐contrast MR angiography , 2000, Journal of magnetic resonance imaging : JMRI.

[3]  A. Bjørnerud,et al.  Effect of NC100150 injection on the 1H NMR linewidth of human whole blood ex vivo: Dependency on blood oxygen tension , 2000, Magnetic resonance in medicine.

[4]  D N Firmin,et al.  Echo‐planar magnetic resonance myocardial perfusion imaging: Parametric map analysis and comparison with thallium SPECT , 2001, Journal of magnetic resonance imaging : JMRI.

[5]  P. Boesiger,et al.  SENSE: Sensitivity encoding for fast MRI , 1999, Magnetic resonance in medicine.

[6]  G. V. von Schulthess,et al.  Assessment of Myocardial Perfusion in Coronary Artery Disease by Magnetic Resonance: A Comparison With Positron Emission Tomography and Coronary Angiography , 2001, Circulation.

[7]  R. Wilson,et al.  Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. , 1997, Radiology.

[8]  Håkan Ahlström,et al.  Evaluation of nonperfused myocardial ischemia with MRI and an intravascular USPIO contrast agent in an ex vivo pig model , 2000, Journal of magnetic resonance imaging : JMRI.

[9]  Guang-Zhong Yang,et al.  First‐pass myocardial perfusion imaging and equilibrium signal changes using the intravascular contrast agent NC100150 injection , 1999, Journal of magnetic resonance imaging : JMRI.

[10]  First-pass myocardial perfusion MR imaging with outer-volume suppression and the intravascular contrast agent NC100150 injection: preliminary results in eight patients. , 2001, Radiology.

[11]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association , 2002, The international journal of cardiovascular imaging.

[12]  D. Pennell,et al.  Use of the intravascular contrast agent NC100150 injection in spin-echo and gradient-echo imaging of the heart. , 1999, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[13]  F. Franconi,et al.  High Field Magnetic Resonance Imaging Evaluation of Superparamagnetic Iron Oxide Nanoparticles in a Permanent Rat Myocardial Infarction , 2003, Investigative radiology.

[14]  C. Lorenz,et al.  High-resolution magnetic resonance coronary angiography of the entire heart using a new blood-pool agent, NC100150 injection: comparison with invasive x-ray angiography in pigs. , 1999, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[15]  A. Bjørnerud,et al.  Assessment of T1 and T  *2 effects in vivo and ex vivo using iron oxide nanoparticles in steady state—dependence on blood volume and water exchange , 2002, Magnetic resonance in medicine.

[16]  B. Sobel,et al.  Estimation of Infarct Size in Man and its Relation to Prognosis , 1972, Circulation.

[17]  R. Kim,et al.  Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study , 2003, The Lancet.

[18]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[19]  C H Lorenz,et al.  Characterization of t1 relaxation and blood‐myocardial contrast enhancement of NC100150 injection in cardiac MRI , 1999, Journal of magnetic resonance imaging : JMRI.

[20]  Maythem Saeed,et al.  MR imaging of spatial extent of microvascular injury in reperfused ischemically injured rat myocardium: value of blood pool ultrasmall superparamagnetic particles of iron oxide. , 2002, Radiology.

[21]  M E Moseley,et al.  Iron–dextran as a magnetic susceptibility contrast agent: Flow‐related contrast effects in the T2‐weighted spin‐echo MRI of normal rat and cat brain , 1992, Magnetic resonance in medicine.

[22]  O. Simonetti,et al.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.

[23]  E. Fleck,et al.  Magnetic Resonance Perfusion Measurements for the Noninvasive Detection of Coronary Artery Disease , 2003, Circulation.